NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay

被引:38
|
作者
Giusti, Delphine [1 ,2 ]
Bini, Estela [1 ]
Terryn, Christine [3 ]
Didier, Kevin [1 ]
Le Jan, Sebastien [1 ]
Gatouillat, Gregory [1 ,2 ]
Durlach, Anne [4 ]
Nesmond, Stephane [1 ]
Muller, Celine [1 ]
Bernard, Philippe [1 ,5 ]
Antonicelli, Frank [1 ,6 ]
Bach Nga Pham [1 ,2 ]
机构
[1] Univ Champagne Ardenne, Lab Dermatol, Fac Med Reims, Reims, France
[2] Univ Champagne Ardenne, Reims Univ Hosp, Lab Immunol, Reims, France
[3] Univ Reims, PICT Platform, Reims, France
[4] Reims Univ Hosp, Lab Pathol, Reims, France
[5] Univ Champagne Ardenne, Reims Univ Hosp, Dept Dermatol, Reims, France
[6] Univ Reims, Dept Biol Sci, Immunol, UFR Odontol, Reims, France
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
关键词
neutrophil extracellular traps; eosinophil extracellular traps; cytokine; autoimmunity; inflammation; bullous pemphigoid; NEUTROPHIL EXTRACELLULAR TRAPS; EXPERIMENTAL-MODELS; BLISTER FORMATION; XVII COLLAGEN; DNA TRAPS; IN-VITRO; AUTOIMMUNE; RELEASE; DISEASE; INHIBITION;
D O I
10.3389/fimmu.2019.00701
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: DNA extracellular traps (ETs), released by neutrophils (NETs), or eosinophils (EETs), play a pathogenic role in several autoimmune disorders. However, to date, NETs have never been investigated in bullous pemphigoid (BP) with respect to clinical and immunological activities, both at baseline and at time of relapse which have been characterized with specific IL-17 and IL-23 patterns. Objective: We sought to assess whether ETs were associated with BP as well as the relative contribution of IL-17 axis cytokines to NET induction. Methods: Skin biopsy specimens were obtained from 11 patients with BR Immuno-detection of neutrophils and eosinophils combined to DNA staining allowed us to investigate the in-situ presence of NETs and EETs using confocal scanning microscopy. NETs release was evaluated ex vivo by stimulating polymorphonuclear cells from BP patients with BP biological fluids in presence of IL-17A and IL-23 or of glucocorticoids. Results: At baseline, ETs were observed in BP lesions at the site of dermal-epidermal cleavage. Despite an important infiltrate of eosinophils, ETs were essentially associated with neutrophils in situ and were not related to BP clinical activity at diagnosis. In situ observation of NETs was associated in 6 among 8 patients with serum capacity of NET induction. Notably both blister fluid and sera from BP patients at diagnosis and at time of relapse could induce NET formation ex vivo. In contrast, a longitudinal investigation showed a decrease of NET formation with time of treatment in patients undergoing remission. Mimicking relapse, complementation of sera from BP patients with ongoing remission with either IL-17A or IL-23 increased NET formation. Conversely, IL-17A inhibited NET formation induced by serum from BP patients with relapse supplemented or not with IL-23. Finally, glucocorticoids also inhibited NET formation ex vivo in BR. Conclusion: NET formation is an associated phenomenon with BP. Furthermore, we showed that IL-23 favored NET formation, whereas the effects of IL-17A are environment dependent. Indeed, IL-17A displayed a protective effect on NET formation when associated with IL-23, showing for the first-time differential effects of these two cytokines in BP.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
    Li, Hao
    Tsokos, George C.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2021, 60 (01) : 31 - 45
  • [32] The Role of IL-23/IL-17 Axis in Lupus Nephritis
    Zhang, Zheng
    Kyttaris, Vasileios C.
    Tsokos, George C.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (05): : 3160 - 3169
  • [33] IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
    Hao Li
    George C. Tsokos
    Clinical Reviews in Allergy & Immunology, 2021, 60 : 31 - 45
  • [34] Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
    Ellen M. Gravallese
    Georg Schett
    Nature Reviews Rheumatology, 2018, 14 : 631 - 640
  • [35] Therapeutic potential of targeting IL-17 and IL-23 in sepsis
    Bosmann, Markus
    Ward, Peter A.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2012, 1
  • [36] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    Ghoreschi, Kamran
    Balato, Anna
    Enerback, Charlotta
    Sabat, Robert
    LANCET, 2021, 397 (10275): : 754 - 766
  • [37] Erratum: The IL-23–IL-17 axis in inflammatory arthritis
    Erik Lubberts
    Nature Reviews Rheumatology, 2015, 11 : 562 - 562
  • [38] The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
    Tsukazaki, Hiroyuki
    Kaito, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 19
  • [39] EXPRESSIONS OF IL-17, IL-21 AND IL-23 IN THE SERUM OF ALLERGIC RHINITIS PATIENTS
    Huang, Xuekun
    Yang, Qintai
    Chen, Yulian
    Li, Peng
    Zhang, Gehua
    Li, Yuan
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2011, 30 (04) : 323 - 327
  • [40] IL-23 and IL-17 in pathogenesis of experimental ocular autoimmunity: requirement for IL-23 may extend beyond its role in sustaining the IL-17 effector response
    Caspi, Rachel
    Silver, Phyllis
    Cua, Daniel
    Chen, Zoe
    Chan, Chi-Chao
    Luger, Dror
    JOURNAL OF IMMUNOLOGY, 2007, 178